SAH-EZH2
This small molecule inhibitor disrupts the EZH2/EPP interaction with a Kd of 320 nM, leading to reduced EZH2 expression and H3K27me3 by the PRC2 complex. It halts proliferation and promotes monocyte-to-macrophage differentiation in MLL-AF9 leukemia models, supporting research into epigenetic therapies for hematological cancers.
Product Specifications
Field of Research
Epigenetics & Chromatin, Metabolism Research; Epigenetics & Chromatin
Molecular Weight
3432.05
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog